Research & Projects

ESCMID Panorama

ESCMID Fungal Infection Study Group - EFISG

News & Activities

12 April 2018

EFISG @ ECCMID 2018 in Madrid, Spain

  • EFISG Meeting, Monday, 23 April, 13.15 - 14.15, Neptuno Room, 2nd Level
10 May 2017

Update on the medical guideline "Diagnosis and management of Aspergillus disease" - in publication process

The draft guideline was under public consultation from 28 March to 09 May 2017.

Once the current manuscript is published, it will appear here along with the comments from the public consultation phase and the author's responses to them.

This guideline is coordinated by the ESCMID Fungal Infection Study Group (EFISG)

05 April 2017

EFISG @ ECCMID 2017 in Vienna, Austria

  • EFISG Meeting, Monday, 24 April, 13.15 - 14.15, Hall B Gallery 1 a+b
28 March 2017

Guideline on the diagnosis and management of Aspergillus disease open for public consultation

The draft version of the medical guideline on the diagnosis and treatment of Aspergillus disease has now entered into the public consultation phase. The guideline is a result of the concerted efforts of ESCMID, through its fungal infections study group (EFISG), the European Confederation of Medical Mycology (ECMM) and the European Respiratory Society (ERS).


Those of you wishing to comment on the manuscript may write to the ESCMID Publications and Medical Guidelines Manager to request the (confidential) draft of the manuscript along with the comments form for listing feedback. We are happy to receive your feedback and comments on the manuscript until 09 May 2017. Please be aware that your comments and the authors’ responses to the comments will be made available online once the guideline is published.

03 February 2017

News on Candida auris

Candida auris is a new species of Candida that is currently causing outbreaks in healthcare settings worldwide. The first outbreak in Europe was described in England in 2015, but there are already cases in Spain.
C. auris is difficult to identify with classical methods and can be misidentified with different species (Rhodotorula glutinis, Saccharomyces cerevisiae, Candida haemulonii, Candida sake, or other species of Candida non-albicans), according to the identification method used. Correct identification can be done by sequencing the ITS or D1-D2 regions or with MALDI-TOF (the species has been included in the last update of Bruker´s library).
C. auris is resistant to fluconazole, and strains resistant to amphotericin B and echinocandins have also been described. From the experience acquired so far, it is known that it is important to detect it as soon as possible to take control measures, due to its high transmission capacity and resistance pattern.
Due to the difficulty of the correct identification of C. auris, if proper identification methods are not available we recommend the referral of suspected invasive isolates to a reference mycology laboratory.
For more information you can visit the following links:

  • Risk Assessment of the European Center for Disease Control (ECDC, direct link)
  • Guidance for the laboratory investigation, management and infection prevention and control from cases of Candida auris elaborated by Public Health England (PHE, direct link)
  • CDC Candida auris website with links to Interim Recommendations, as well as links to papers on a global WGS analysis and investigation of the first seven US cases
  • ECCMID 2017 will present new data on this new pathogen. Check the scientific programme, which will be published on the congress website in the course of February
  • Become EFISG member to stay updated on new developments in the fungal field

- The EFISG Executive Committee

01 November 2016

EFISG comments on JAC supplement on antifungal stewardship

The Journal of Antimicrobial Chemotherapy on 2 November published a supplement on antifungal stewardship, which is a core element in patient care at hospitals. EFISG welcomes and supports this initiative and takes this opportunity to highlight these specific recommendations on antifungal stewardship (online access to this supplement). You may have a look at the supplement's table of content as well as EFISG's comment.

Here is the new EFISG Executive Committee:

  • Cornelia Lass-Flörl, Austria (Chairperson)
  • Sevtap Arikan-Akdagli, Turkey (Secretary)
  • Ana Alastruey-Izquierdo, Spain (Treasurer)

We thank all previous Executive Committee for their excellent work over the last years. We are looking forward to continuing this work.

Your new Executive Committee

  • Sunday, 10 April 2016
    9.00 h - 11.00 h (Hall J)
    2-hour Symposium SY048: Approaches to individualized management of invasive fungal disease
    11.30 h - 12.30 h (Hall K)
    1-hour Symposium SY059: Recent top papers in mycology
    13.15 h - 14.15 h (Room: G109)
    EFISG Meeting: All interested persons are cordially invited to join the meeting and plan future Study Group activities.
    14.30 h - 15.30 h (Hall J)
    Keynote Lecture KL069: The fungal microbiome and human health
  • Monday, 11 April 2016
    7.45 h - 8.45 h (Hall E104/105)
    Meet-the-Expert Session ME083: Antifungal stewardship: do we need it in our hospitals?
  • Tuesday, 12 April 2016
    13.30 h - 15.30 h (Hall G)
    2-hour Symposium SY148: How to diagnose more fungal disease and less colonization

Pasteur course: Medical mycology
21 March - 15 April 2016
Paris, France

Directors: Françoise Dromer & Olivier Lortholary

Course website

This four-week course is intended for microbiologists (MD, PhD, VetD) practicing mycology in hospital laboratories to catch up with the most recent advances in diagnosis and identification procedures and principles of therapy for fungal infections.

  • Saturday, 25 April 2015
    08.45 - 10.45 (Hall C)
    EFISG Educational Workshop EW03: Optimizing antifungal therapy - bridging laboratory and clinical expertise.
    16.30 - 18.30 (Hall C)
    EFSIG Symposium SY07: Clinical approach in febrile immunocompromised patients with pulmonary infiltrates. Organized jointly with the International Immunocompromised Host Society (ICHS)
  • Sunday, 26 April 2015
    14.30 - 15.30 (Hall H)
    EFISG Symposium SY20: Recent top papers in fungal infections.
    16.00 - 18.00 (Hall D)
    EFISG Symposium SY24: Challenges in fungal infections
    18.15 - 19.15 (Room 19)
    EFISG Business Meeting: All interested persons are cordially invited to join the meeting and plan future Study Group activities.
  • Tuesday, 28 April 2015
    07.45 - 08.45 (Hall M)
    EFISG Meet-the-Expert Session ME17: How do I treat aspergillosis and mucormycosis?
    11.30 - 12.30 (Hall H)
    EFISG Symposium SY50: Fungal PCR
  • Saturday, 10 May 2014
    11.00 - 13.00 (Hall J)
    Educational Workshop 19: ESCMID guidelines for diagnosis and treatment of Aspergillus diseases, organised jointly with the ESCMID Study Group for Infections in Compromised Hosts (ESGICH); the European Confederation of Medical Mycology (ECMM); the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI).
  • Sunday, 11 May 2014
    18.15 - 19.15 (Room 127/128)
    EFISG Business Meeting: All interested persons are cordially invited to join the meeting and plan future Study Group activities.
  • Monday, 12 May 2014
    7.45 - 8.45 (Hall F)
    EFISG Meet-the-Expert Session: New nomenclature: new species - any meaning for clinical relevance?
    11.30 - 12.30 (Hall C)
    EFISG Keynote Lecture: Fighting against fungal infections: cells on the front lines.
    14.30 - 15.30 (Hall E)
    EFISG Symposium: T-cells in invasive aspergillosis.
    16.00 - 18.00 (Hall A)
    EFISG Symposium: Cryptococcal infections in HIV-infected patients: what is new in 2014? Organised jointly with the European AIDS Clinical Society (EACS).
    16.00 - 18.00 (Hall E)
    EFISG Symposium: Predicting the future in fungal diagnosis and therapy, organised jointly with the Mycology Study Group (MSG) of the International Society for Human and Animal Mycology (ISHAM).
  • Saturday, 27 April 2013
    08.45 - 10.45 (Hall E)
    EFISG Educational Workshop 9 (jointly organised with ECMM): ESCMID/ECMM Guideline: diagnosis and therapy of rare and emerging fungi
  • Sunday, 28 April 2013
    07.45 - 08.45 (Hall C)
    EFISG Meet-the-Expert Session (jointly organised with EUCAST): Do we need both, species identification and MICs to guide antifungal therapy?
    14.30 - 15.30 (Hall C)
    EFISG Symposium (jointly organised with ESGCP): Azole resistance
    18.15 - 19.15 (Hall 10)
    EFISG Business Meeting
    : All interested persons are cordially invited to join the meeting and plan future EFISG activities.
  • Tuesday, 30 April 2013
    13.30 - 15.30 (Hall C)
    EFISG Symposium: Pneumocystis: the pathogens - clinical symptoms, diagnosis and management

For more details, please check the ECCMID programme.

ECCMID programme

  • 31 March, 8.45-10.45
    Educational Workshop EW01 "State-of-the-art management of infections following solid organ transplantation"
    Jointly arranged with EFISG and ESGICH.
  • 31 March, 11.00-13.00
    Educational Workshop EW11 "Common statements in the literature regarding invasive fungal diseases - truth or cliché"
    Arranged with EFISG and the European Organisation for Research and Treatment of Cancer (EORTC).
  • 1 April, 9.00-11.00
    2-hour Symposium "Diagnosing fungal diseases: future perspectives"
  • 3 April, 7.45-8.45
    Meet-the-Expert Session "Fungal taxonomy for the clinician in 2012"
  • 1 April, 13.00-14.00 (Meeting Room 12)
    EFISG Business Meeting

For more details, please check the ECCMID programme.

ECCMID programme

Infections in Immunocompromised Hosts

EFISG endorsed this ESCMID Conference in Istanbul, Turkey, 17 - 18 November 2011.

Aspergillosis: from Allergy to Invasive Disease

EFISG organised this ESCMID PGTW in Manchester, United Kingdom, 25 - 26 May 2011.

  • 7 May, 8.45-13.00
    Educational Workshop EW02 "Fungi in the respiratory tract & antifungal stewardship"
    Arranged by EFISG/ECMM (European Confederation of Medical Mycology)/GRACE (Genomics to combat Resistance against Antibiotics in Community-acquired LRTI in Europe).
  • 7 May, 11.00-13.00
    Educational Workshop EW16 "Presentation of the ESCMID diagnostic & management guideline for Candida diseases 2011"
  • 8 May, 12.30-13.30 (Room Amber 1)
    EFISG Business Meeting
    All interested persons are cordially invited to join the meeting and plan future EFISG activities.

For more details, please check the ECCMID/ICC programme.

ECCMID/ICC programme

Biofilms in Nosocomial Fungal Infections

EFISG organised this ESCMID PGEC in collaboration with the Biofilm Study Group (ESGB) in Paris, France, 31 Jan - 1 Feb 2011.


This is a database project for analysis of rare fungal infections under the auspices of EFISG, ISHAM and other scientific societies.


Last update: 05 April 2017

Download the latest Annual Report.